Reveal highly functional active subsets of tumor cells that drive resistance
Our Award-Winning Single-Cell Tumor Resistance System (IsoLight) detects pathways in tumor cells to help researchers design effective therapeutic strategies.
The IsoLight then automatically translates this data into insight, generating two unique metrics (FHI™ & SNAI™), revealing the pathways that are adapting to the therapy and driving resistance.
See What’s Next in Immunotherapy
Learn how tumor signaling and pathway analysis makes the difference
Explore by Tumor Types
Explore by Target Optimization
How It Works
Single-Cell Tumor Resistance
- Our chip measures the range of 32 intracellular proteins and phosphoproteins that capture key druggable pathways and dictate resistance to therapy
- This panel is measured from each of 1000+ single tumor cells
- The early precursor cells that dictate resistant pathways are detected
